Archives of Epilepsy, 2018 Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack
Zeynep ÖZÖZEN AYAS +1 more
doaj +1 more source
Self-controlled case series with multiple event types [PDF]
, 2017 Self-controlled case series methods for events that may be classified as one of several types are described. When the event is non-recurrent, the different types correspond to competing risks.
Douglas, Ian J. +4 more
core +1 more source
Integration of Tobacco Treatment Services into Cancer Care at Stanford. [PDF]
, 2020 As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 ...
Fielding-Singh, Priya +7 more
core +2 more sources
Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI
Case Reports in Psychiatry, 2015 Bupropion hydrochloride (HCI) is an antidepressant that acts as a norepinephrine and dopamine reuptake inhibitor and has three different dosage forms including immediate release (IR), sustained release (SR), and extended release (ER).
Filiz Izci +4 more
doaj +1 more source
Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones [PDF]
, 2017 Synthetic cathinones are a new class of psychostimulant substances. Rarely, they can cause liver injury but associated mechanisms are not completely elucidated.
Krähenbühl, Stephan +2 more
core +1 more source
General practitioners' beliefs about effectiveness and intentions to recommend smoking cessation services: qualitative and quantitative studies [PDF]
, 2006 Background: General practitioners' (GPs) negative beliefs about nicotine dependence medications may act as barriers to prescribing them. Methods: Study 1: Twenty-five GPs from 16 practices across London were interviewed in this qualitative study ...
Florian Vogt +42 more
core +3 more sources
Frontiers in Psychiatry, 2018 Background: Previous research indicates that antidepressants can restore the balance between negative and positive emotional processing early in treatment, indicating a role of this effect in later mood improvement.
Annabel E. L. Walsh +9 more
doaj +1 more source
Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis. [PDF]
Obesity (Silver Spring)ABSTRACT Objective The present study examined the safety and efficacy of the fixed‐dose, extended‐release combination of naltrexone and bupropion (NB‐ER) in individuals with overweight/obesity and mild to moderate symptoms of depression. Methods Data were pooled from four double‐blind, placebo‐controlled trials.
Tronieri JS +5 more
europepmc +2 more sources
Enhanced neural response to anticipation, effort and consummation of reward and aversion during Bupropion treatment [PDF]
, 2016 Background We have previously shown that the selective serotonergic re-uptake inhibitor, citalopram, reduces the neural response to reward and aversion in healthy volunteers. We suggest that this inhibitory effect might underlie the emotional blunting
C. McCabe +5 more
core +1 more source
Stereoselective Biotransformation: Transfer of Learning to Advance Drug Metabolism and Biocatalysis
Angewandte Chemie International Edition, EarlyView.Understanding stereoselective biotransformations has implications for predicting drug disposition and response and may also inspire novel biocatalytic and biomimetic strategies to address challenges in metabolite and API synthesis. ABSTRACT Chirality is an important determinant of drug action, as enantiomers can exhibit markedly different ...
Grace A. Okunlola, Godwin A. Aleku
wiley +1 more source